CLN-978-SJ-101
CLN-978-SJ-101 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren’s Disease Pathologie Maladie de…
CYTB323M12101B
CYTB323M12101B A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren’s Disease…
DAFFODIL
DAFFODIL Nipocalimab in Moderate to Severe Sjogren’s Disease Pathologie Maladie de Sjögren Établissement CHU de Brest Promoteur JANSSEN Avancement projet…
HZNP-DAZ-303
HZNP-DAZ-303 A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren’s Syndrome (SS) With Moderate-to-Severe Symptom State Pathologie Maladie…
NEPTUNUS 2 Ext _ CVAY736A2301E1
NEPTUNUS 2 Ext – CVAY736A2301E1 A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in…